• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一项针对有症状的良性前列腺增生(BPH)男性的为期两周的双盲、安慰剂对照试验,该试验使用了香堇、天蓝蓟和酸浆的混合物。

A two-week, double-blind, placebo-controlled trial of Viola odorata, Echium amoenum and Physalis alkekengi mixture in symptomatic benign prostate hyperplasia (BPH) men.

作者信息

Beiraghdar Fatemeh, Einollahi Behzad, Ghadyani Alireza, Panahi Yunes, Hadjiakhoondi Abbas, Vazirian Mahdi, Salarytabar Ali, Darvishi Behrad

机构信息

a Nephrology and Urology Research Center , Baghiatallah University of Medical Sciences , Tehran , Iran.

b Department of Pharmacognosy and Medical Plants Research Center Faculty of Pharmacy , Tehran University of Medical Sciences , Tehran , Iran.

出版信息

Pharm Biol. 2017 Dec;55(1):1800-1805. doi: 10.1080/13880209.2017.1328445.

DOI:10.1080/13880209.2017.1328445
PMID:28532232
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6130621/
Abstract

CONTEXT

As an alternative approach, administration of phytotherapeutic agents in management of benign prostate hyperplasia (BPH), is rapidly growing each day. Different authors have indicated effectiveness of Viola odorata L. (Violaceae), Echium amoenum Fisch. & C.A.Mey. (Boraginaceae) and Physalis alkekengi L. (Solanaceae) in treatment of BPH. However, none have reported the beneficial outcomes of the mixture yet.

OBJECTIVE

This study evaluates the therapeutical effects of V. odorata, E. amoenum and P. alkekengi mixture on symptomatic BPH patients.

MATERIALS AND METHODS

Eighty six symptomatic BPH patients with International Prostate Symptom Score (IPSS) of more than 13 and prostate volume of more than 30 cm were randomly allocated to receive a two-week course of placebo (control group) or 1 mL of mixed hydro-alcoholic solution of P. alkekengi, E. amoenum and V. odorata extracts (1.5, 1 and 1.5% respectively) (treatment group).

RESULTS

IPSS score of incomplete urination (42.3 ± 2.04%), frequency of urination (20.08 ± 1.02%), intermittency (40.78 ± 2.16%), urgency (60.91 ± 3.14%), weak stream (50.58 ± 2.14%), straining (55.67 ± 2.53%) and nocturia (40.14 ± 1.89%) in treatment group were significantly decreased after treatment compare to placebo receiving group. Furthermore, the prostate volume (16.92 ± 0.89%) and extant urine volume (28.12 ± 1.36%) also significantly decreased in treatment group compared to control group. No significant side effects or abnormalities in biochemical tests and urinalysis were observed throughout the study.

DISCUSSION AND CONCLUSIONS

Based on results, mentioned mixture is safe and effective in improving life quality of patients suffering from BPH.

摘要

背景

作为一种替代方法,植物治疗剂在良性前列腺增生(BPH)管理中的应用日益广泛。不同作者已表明香堇菜(堇菜科)、阿米尼亚车叶草(紫草科)和酸浆(茄科)在治疗BPH方面的有效性。然而,尚无关于该混合物有益效果的报道。

目的

本研究评估香堇菜、阿米尼亚车叶草和酸浆混合物对有症状的BPH患者的治疗效果。

材料与方法

86例国际前列腺症状评分(IPSS)超过13且前列腺体积超过30 cm的有症状BPH患者被随机分配接受为期两周的安慰剂疗程(对照组)或1 mL酸浆、阿米尼亚车叶草和香堇菜提取物的混合水醇溶液(分别为1.5%、1%和1.5%)(治疗组)。

结果

与接受安慰剂组相比,治疗组治疗后排尿不完全的IPSS评分(42.3±2.04%)、排尿频率(20.08±1.02%)、间歇性(40.78±2.16%)、尿急(60.91±3.14%)、尿流无力(50.58±2.14%)、排尿费力(55.67±2.53%)和夜尿(40.14±1.89%)均显著降低。此外,与对照组相比,治疗组的前列腺体积(16.92±0.89%)和残余尿量(28.12±1.36%)也显著降低。在整个研究过程中未观察到明显的副作用或生化检查及尿液分析异常。

讨论与结论

基于结果,上述混合物在改善BPH患者生活质量方面安全有效。

相似文献

1
A two-week, double-blind, placebo-controlled trial of Viola odorata, Echium amoenum and Physalis alkekengi mixture in symptomatic benign prostate hyperplasia (BPH) men.一项针对有症状的良性前列腺增生(BPH)男性的为期两周的双盲、安慰剂对照试验,该试验使用了香堇、天蓝蓟和酸浆的混合物。
Pharm Biol. 2017 Dec;55(1):1800-1805. doi: 10.1080/13880209.2017.1328445.
2
Comparison of Murraya koenigii- and Tribulus terrestris-based oral formulation versus tamsulosin in the treatment of benign prostatic hyperplasia in men aged >50 years: a double-blind, double-dummy, randomized controlled trial.比较九里香-蒺藜口服制剂与坦索罗辛治疗 50 岁以上男性良性前列腺增生的疗效:一项双盲、双模拟、随机对照试验。
Clin Ther. 2011 Dec;33(12):1943-52. doi: 10.1016/j.clinthera.2011.11.005.
3
Serenoa repens extract for benign prostate hyperplasia: a randomized controlled trial.用于良性前列腺增生的锯叶棕提取物:一项随机对照试验。
BJU Int. 2003 Aug;92(3):267-70. doi: 10.1046/j.1464-410x.2003.04316.x.
4
A phase II randomised double-blind placebo-controlled clinical trial investigating the efficacy and safety of ProstateEZE Max: a herbal medicine preparation for the management of symptoms of benign prostatic hypertrophy.一项评估 ProstateEZE Max(一种草药制剂)治疗良性前列腺增生症症状的疗效和安全性的 II 期随机双盲安慰剂对照临床试验。
Complement Ther Med. 2013 Jun;21(3):172-9. doi: 10.1016/j.ctim.2013.01.007. Epub 2013 Feb 23.
5
Epilobium angustifolium L. extract with high content in oenothein B on benign prostatic hyperplasia: A monocentric, randomized, double-blind, placebo-controlled clinical trial.柳叶菜提取物中高含量的樱黄素 B 治疗良性前列腺增生:一项单中心、随机、双盲、安慰剂对照的临床试验。
Biomed Pharmacother. 2021 Jun;138:111414. doi: 10.1016/j.biopha.2021.111414. Epub 2021 Mar 23.
6
Efficacy and safety of tadalafil once daily in the treatment of men with lower urinary tract symptoms suggestive of benign prostatic hyperplasia: results of an international randomized, double-blind, placebo-controlled trial.每日一次他达拉非治疗下尿路症状提示良性前列腺增生症男性患者的疗效和安全性:一项国际随机、双盲、安慰剂对照试验的结果。
Eur Urol. 2011 Nov;60(5):1105-13. doi: 10.1016/j.eururo.2011.08.005. Epub 2011 Aug 12.
7
Urtica dioica for treatment of benign prostatic hyperplasia: a prospective, randomized, double-blind, placebo-controlled, crossover study.荨麻治疗良性前列腺增生:一项前瞻性、随机、双盲、安慰剂对照、交叉研究。
J Herb Pharmacother. 2005;5(4):1-11.
8
Cernilton for benign prostatic hyperplasia.舍尼通用于良性前列腺增生。
Cochrane Database Syst Rev. 2000(2):CD001042. doi: 10.1002/14651858.CD001042.
9
Comparison of Anti BPH capsule (herbal) and Terazosin HCl in the treatment of benign prostate hyperplasia.抗前列腺增生胶囊(草药)与盐酸特拉唑嗪治疗良性前列腺增生的比较。
Pak J Pharm Sci. 2017 Jan;30(1 Suppl):289-293.
10
The influence of baseline parameters on changes in international prostate symptom score with dutasteride, tamsulosin, and combination therapy among men with symptomatic benign prostatic hyperplasia and an enlarged prostate: 2-year data from the CombAT study.基线参数对有症状的良性前列腺增生和前列腺肿大男性使用度他雄胺、坦索罗辛及联合治疗后国际前列腺症状评分变化的影响:CombAT研究的2年数据
Eur Urol. 2009 Feb;55(2):461-71. doi: 10.1016/j.eururo.2008.10.037. Epub 2008 Nov 6.

引用本文的文献

1
and Rosmarinic Acid Suppress the Growth and Metastasis of Gastric Cancer AGS Cells by Promoting Apoptosis and Inhibiting EMT.迷迭香酸通过促进细胞凋亡和抑制上皮-间质转化来抑制胃癌AGS细胞的生长和转移。
Int J Mol Sci. 2024 Nov 30;25(23):12909. doi: 10.3390/ijms252312909.
2
Effects of Viola odorata syrup on sleep quality in menopausal women: a randomized, triple-blind, controlled trial.紫堇糖浆对围绝经期妇女睡眠质量的影响:一项随机、三盲、对照试验。
Sleep Breath. 2024 Jun;28(3):1137-1144. doi: 10.1007/s11325-023-02979-x. Epub 2024 Jan 5.
3
Nutritional and Pharmaceutical Applications of Under-Explored Knottin Peptide-Rich Phytomedicines.未充分探索的富含结蛋白肽植物药的营养与制药应用
Plants (Basel). 2022 Nov 28;11(23):3271. doi: 10.3390/plants11233271.
4
The effect of pharmacotherapy on prostate volume, prostate perfusion and prostate-specific antigen (prostate morphometric parameters) in patients with lower urinary tract symptoms and benign prostatic obstruction. A systematic review and meta-analysis.药物治疗对下尿路症状和良性前列腺梗阻患者前列腺体积、前列腺灌注及前列腺特异性抗原(前列腺形态学参数)的影响。一项系统评价和荟萃分析。
Cent European J Urol. 2021;74(3):388-421. doi: 10.5173/ceju.2021.132.R1. Epub 2021 Aug 11.

本文引用的文献

1
Review of Prostate Anatomy and Embryology and the Etiology of Benign Prostatic Hyperplasia.前列腺解剖学与胚胎学及良性前列腺增生病因学综述
Urol Clin North Am. 2016 Aug;43(3):279-88. doi: 10.1016/j.ucl.2016.04.012.
2
Phytotherapy for Benign Prostatic Hyperplasia.良性前列腺增生的植物疗法
Curr Urol Rep. 2016 Jul;17(7):53. doi: 10.1007/s11934-016-0609-z.
3
Complementary and alternative medications for benign prostatic hyperplasia.用于良性前列腺增生的补充和替代药物。
Can J Urol. 2015 Oct;22 Suppl 1:18-23.
4
Management of Benign Prostatic Hyperplasia.良性前列腺增生症的管理。
Annu Rev Med. 2016;67:137-51. doi: 10.1146/annurev-med-063014-123902. Epub 2015 Sep 2.
5
Drug-related problems in patients with benign prostatic hyperplasia: a cross sectional retrospective study.良性前列腺增生患者的药物相关问题:一项横断面回顾性研究。
PLoS One. 2014 Jan 27;9(1):e86215. doi: 10.1371/journal.pone.0086215. eCollection 2014.
6
The association of lower urinary tract symptoms, depression and suicidal ideation: data from the 2005-2006 and 2007-2008 National Health and Nutrition Examination Survey.下尿路症状、抑郁与自杀意念之间的关联:来自2005 - 2006年及2007 - 2008年国家健康与营养检查调查的数据。
J Urol. 2014 May;191(5):1333-9. doi: 10.1016/j.juro.2013.12.012. Epub 2013 Dec 14.
7
Correlation between benign prostatic hyperplasia and inflammation.良性前列腺增生与炎症的相关性。
Curr Opin Urol. 2013 Jan;23(1):5-10. doi: 10.1097/MOU.0b013e32835abd4a.
8
Various treatment options for benign prostatic hyperplasia: A current update.良性前列腺增生的各种治疗选择:最新进展
J Midlife Health. 2012 Jan;3(1):10-9. doi: 10.4103/0976-7800.98811.
9
Serenoa repens monotherapy for benign prostatic hyperplasia (BPH): an updated Cochrane systematic review.锯叶棕单药治疗良性前列腺增生症(BPH):一项更新的 Cochrane 系统评价。
BJU Int. 2012 Jun;109(12):1756-61. doi: 10.1111/j.1464-410X.2012.11172.x. Epub 2012 May 2.
10
Under the tip of the iceberg: psychological factors in incontinence.冰山一角之下:尿失禁的心理因素。
Neurourol Urodyn. 2012 Jun;31(5):669-71. doi: 10.1002/nau.21216. Epub 2012 Mar 30.